Have a personal or library account? Click to login
Measurement of red blood cell-bound C3b and C3d using an enzyme-linked direct antiglobulin test Cover

Measurement of red blood cell-bound C3b and C3d using an enzyme-linked direct antiglobulin test

Paid access
|Nov 2020

References

  1. Sokol RJ, Hewitt S, Booker DJ, Bailey A. Red cell autoantibodies, multiple immunoglobulin classes, and autoimmune hemolysis. Transfusion 1990;30:714–7.10.1046/j.1537-2995.1990.30891020331.x
  2. Sokol RJ, Hewitt S, Booker DJ, Bailey A. Erythrocyte autoantibodies, subclasses of IgG and autoimmune haemolysis. Autoimmunity 1990;6:99–104.10.3109/08916939008993374
  3. Sokol RJ, Booker DJ, Stamps R. The pathology of autoimmune haemolytic anaemia. J Clin Pathol 1992; 45:1047–52.10.1136/jcp.45.12.1047
  4. Rosse WF. Quantitative immunology of immune hemolytic anemia. II. The relationship of cell-bound antibody to hemolysis and treatment. J Clin Invest 1971;50:734–43.10.1172/JCI106544
  5. van der Meulen FW, de Bruin HG, Goosen PCM, et al. Quantitative aspects of the destruction of red cells sensitized with IgG1 autoantibodies: an application of flow cytofluorometry. Br J Haematol 1980; 46:47–56.10.1111/j.1365-2141.1980.tb05934.x
  6. Garratty G. The significance of IgG on the red cell surface. Transfus Med Rev 1987;I:47–57.10.1016/S0887-7963(87)70005-4
  7. Sokol RJ, Hewitt S, Booker DJ, Stamps R. Small quantities of erythrocyte bound immunoglobulins and autoimmune haemolysis. J Clin Pathol 1987;40:254–7.10.1136/jcp.40.3.25411408943558858
  8. Gilliland BC, Baxter E, Evans RS. Red-cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med 1971;285:252–6.10.1056/NEJM1971072928505034103812
  9. Gilliland BC. Coombs-negative immune hemolytic anemia. Semin Hematol 1976;13:267–75.
  10. Freedman J, Ho M, Barefoot C. Red cell-bound C3d in selected hospital patients. Transfusion 1982; 22:515–20.10.1046/j.1537-2995.1982.22683068616.x6216638
  11. Munn LR, Chaplin H. Rosette formation by sensitized human red cells-effects of source of peripheral leukocyte monolayers. Vox Sang 1977;33:129–42.
  12. Garratty G. The clinical significance (and insignificance) of red-cell-bound IgG and complement. In: Wallace ME, Levitt JS, eds. Current applications and interpretation of the direct antiglobulin test. Arlington, VA: American Association of Blood Banks, 1988:1–24.
  13. Garratty G. The significance of complement in immunohematology. Crit Rev Clin Lab Sci 1989;20:25–56.10.3109/104083684091657696373144
  14. Kurlander RJ, Rosse WF, Logue GL. Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis. J Clin Invest 1978;61:1309–19.10.1172/JCI109048
  15. Kurlander RJ, Rosse WF. Monocyte-mediated destruction in the presence of serum of red cells coated with antibody. Blood 1979;54:1131–9.10.1182/blood.V54.5.1131.1131
  16. Sokol RJ, Hewitt S, Booker DJ, Stamps R, Booth JR. An enzyme-linked direct antiglobulin test for assessing erythrocyte bound immunoglobulins. J Immunol Methods 1988;106:31–5.10.1016/0022-1759(88)90268-2
  17. Sokol RJ, Hewitt S, Booker DJ, Morris BM. Patients with red cell autoantibodies: selection of blood for transfusion. Clin Lab Haematol 1988;10:257–64.10.1111/j.1365-2257.1988.tb00019.x3180694
  18. Sokol RJ, Booker DJ, Stamps R. Investigation of patients with autoimmune haemolytic anemia and provision of blood for transfusion. J Clin Pathol 1995; 48:602–10.10.1136/jcp.48.7.6025027087560164
  19. Mack C. Essentials of statistics for scientists and technologists. New York: Plenum Press, 1967.10.1007/978-1-4684-7965-2
  20. Sokol RJ, Hudson G, James NT, Frost IJ, Wales J. Human macrophage development: a morphometric study. J Anat 1987;151:27–35.
  21. Gilman GE, Kennedy MS, Lott JA, Powers JD, Waheed A, Senhauser DA. Further improvement of the enzyme-linked antiglobulin test (ELAT) for erythrocyte antibodies. Am J Clin Pathol 1982;77:206–10.10.1093/ajcp/77.2.2067039301
  22. Postoway N, Nance SJ, Garratty G. Variables affecting the enzyme-linked antiglobulin test when detecting and quantitating IgG red cell antibodies. Med Lab Sci 1985;42:11–9.
  23. Rasmussen JM, Jepsen HH, Teisner B, Holmskov- Nielsen U, Rasmussen GG, Svehag SE. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with Factor I deficiency and with autoimmune diseases. Vox Sang 1989;56:262–9.10.1111/j.1423-0410.1989.tb02039.x2474900
  24. Kiruba R, Han P. Quantitation of red cell-bound immunoglobulin and complement using enzyme- linked antiglobulin consumption assay. Transfusion 1988;28:519–24.10.1046/j.1537-2995.1988.28689059023.x3194927
  25. Chaplin H, Nasongkla M, Monroe MC. Quantitation of red blood cell-bound C3d in normal subjects and random hospitalized patients. Br J Haematol 1981;48:69–78.10.1111/j.1365-2141.1981.00069.x6972779
  26. Freedman J, Barefoot C. Red blood cell-bound C3d in normal subjects and in random hospital patients. Transfusion 1982;22:511–4.10.1046/j.1537-2995.1982.22683068615.x
  27. Merry AH, Thomson EE, Rawlinson VI, Stratton F. The quantification of C3 fragments on erythrocytes: estimation of C3 fragments in normal cells, acquired haemolytic anaemia cases and correlation with agglutination of sensitised cells. Clin Lab Haematol 1983;5:387–97.10.1111/j.1365-2257.1983.tb00512.x
  28. Giles CM, Davies KA, Walport MJ. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination. Transfusion 1991;31:222–8.10.1046/j.1537-2995.1991.31391165171.x
  29. Garratty G. Effect of cell-bound proteins on the in vivo survival of circulating blood cells. Gerontology 1991;37:68–94.10.1159/000213252
  30. Hamilton RG, Adkinson NF. Quantitative aspects of solid phase immunoassays. In: Kemeny DM, Challacombe SJ, eds. ELISA and other solid phase immunoassays. New York: Wiley, 1988, 57–84.
  31. Merry AH. Quantitative aspects of the antiglobulin test for red cell-bound IgG, C3d and C3g. Biotest Bull 1986;1:53–8.
  32. Freedman J. The significance of complement on the red cell surface. Transfus Med Rev 1987;1:58–70.10.1016/S0887-7963(87)70006-6
  33. Roitt I, Brostoff J, Male D. Immunology. 4th ed. London: Mosby, 1996.
  34. Kay MMB. Drosophila to bacteriophage to erythrocyte: the erythrocyte as a model for molecular and membrane aging of terminally differentiated cells. Gerontology 1991;37:5–32.10.1159/000213250
  35. Kay MMB, Marchalonis JJ, Schluter SF, Bosman G. Human erythrocyte aging: cellular and molecular biology. Transfus Med Rev 1991;V:173–95.10.1016/S0887-7963(91)70207-1
  36. Gershon H. Is the sequestration of aged erythrocytes mediated by natural autoantibodies? Isr J Med Sci 1992;28:818–28.
  37. Gershon H. Do natural autoantibodies play a role in physiologic red blood cell sequestration? Isr J Med Sci 1993;29:167–73.
  38. Siegel I, Liu TL, Gleicher N. The red-cell immune system. Lancet 1981;ii:556–9.10.1016/S0140-6736(81)90941-7
  39. Schifferli JA, Ng YC, Peters DK. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 1986;315:488–95.10.1056/NEJM198608213150805
  40. Schifferli JA, Ng YC. The role of complement in the processing of immune complexes. Ballière’s Clin Immunol Allergy 1988;2:319–34.
  41. Halma C, van Es LA, Daha MR. A newly discovered function of the erythrocyte: transport of immune complexes to the liver. Neth J Med 1992;41:245–54.
  42. Burkhart P, Rosenfield RE, Hsu TCS, et al. Instrumented PVP-augmented antiglobulin tests. I. Detection of allogeneic antibodies coating otherwise normal erythrocytes. Vox Sang 1974;26:289–304.
  43. Kaplan AP. The Hageman factor dependent pathways of human plasma. Microvasc Res 1974;8:97–111.10.1016/0026-2862(74)90068-5
  44. Lachmann PJ. The control of homologous lysis. Immunol Today 1991;12:312–5.10.1016/0167-5699(91)90005-E
  45. Lachmann PJ, Voak D, Oldroyd RG, Downie DM, Bevan PC. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes. Vox Sang 1983;45:367–72.10.1111/j.1423-0410.1983.tb01928.x6605620
  46. Fischer JT, Petz LD, Garratty G, Cooper NR. Correlation between quantitative assay of red cellbound C3, serology reactions and hemolytic anemia. Blood 1974;44:359–71.10.1182/blood.V44.3.359.359
  47. Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM and complement-fixing sites. J Clin Invest 1972; 51:575–82.10.1172/JCI1068463021634536807
  48. Heddle NM, Turchyn KL, Kelton JG. Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a non-reactive eluate, and no evidence of hemolysis (abstract). Transfusion 1985; 25:451.
DOI: https://doi.org/10.21307/immunohematology-2019-727 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 123 - 131
Published on: Nov 9, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 J.D. Bellamy, D.J. Booker, N.T. James, R. Stamps, R.J. Sokol, published by American National Red Cross
This work is licensed under the Creative Commons License.